Alterity Therapeutics reported asset growth of 20.54% for the quarter ended Jun 2026. These growth metrics cover 38 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Growth MetricsGrowth | Jun2010 | Oct2010 | Dec2010 | Jun2011 | Dec2011 | Jun2012 | Oct2012 | Dec2012 | Jun2013 | Oct2013 | Dec2013 | Jun2014 | Sep2014 | Dec2014 | Jun2015 | Dec2015 | Jun2016 | Sep2016 | Dec2016 | Jun2017 | Dec2017 | Jun2018 | Dec2018 | Jun2019 | Dec2019 | Jun2020 | Dec2020 | Jun2021 | Dec2021 | Jun2022 | Dec2022 | Jun2023 | Dec2023 | Jun2024 | Dec2024 | Jun2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth Ratios | ||||||||||||||||||||||||||||||||||||||
| Total Debt (QoQ) | ||||||||||||||||||||||||||||||||||||||
| Total Debt Growth (5y) | 38.78% | 12.19% | -23.48% | 63.93% | ||||||||||||||||||||||||||||||||||
| Total Debt Growth (3y) | 35.82% | 65.77% | 54.90% | 46.46% | ||||||||||||||||||||||||||||||||||
| Total Debt Growth (1y) | 43.03% | -124.29% | 1,169.68% | 20.92% | ||||||||||||||||||||||||||||||||||
| Share-based Compensation Growth (3y)Stock Comp. Growth (3y) | -68.43% | -34.42% | ||||||||||||||||||||||||||||||||||||
| Share-based Compensation Growth (1y)Stock Comp. Growth (1y) | 3,049.91% | 54.57% | ||||||||||||||||||||||||||||||||||||
| Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ) | 40.42% | |||||||||||||||||||||||||||||||||||||
| Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y) | -8.96% | -13.25% | -17.02% | 3.81% | 0.22% | -5.28% | 16.11% | -4.58% | -6.94% | 5.39% | -5.29% | 24.40% | 24.76% | -4.86% | -4.52% | -8.93% | -35.03% | -37.87% | -44.91% | -61.16% | ||||||||||||||||||
| Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y) | -14.71% | -19.13% | -20.38% | 15.20% | 9.07% | 23.57% | 46.83% | 4.66% | 5.00% | -23.46% | -22.38% | 27.38% | -10.26% | 14.63% | 13.83% | -3.13% | -21.64% | -67.09% | -73.11% | -82.81% | ||||||||||||||||||
| Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) | -20.36% | 30.87% | -24.29% | 121.56% | 115.22% | -34.93% | 94.29% | -20.49% | -72.31% | -13.33% | -13.08% | 199.91% | 200.33% | -42.04% | -43.50% | -47.71% | -71.64% | -88.24% | -87.87% | -91.73% | ||||||||||||||||||
| Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) | -1.55% | -37.71% | ||||||||||||||||||||||||||||||||||||
| Net Income Growth (3y) | 56.93% | -14.40% | 12.04% | -5.18% | ||||||||||||||||||||||||||||||||||
| Net Income Growth (1y) | 233.33% | 1.84% | 1.55% | -10.45% | 37.71% | -38.11% | 0.58% | 23.71% | ||||||||||||||||||||||||||||||
| Net Cash Flow Growth (5y)NCF Growth (5y) | 31.39% | 27.69% | ||||||||||||||||||||||||||||||||||||
| Net Cash Flow Growth (3y)NCF Growth (3y) | 0.80% | |||||||||||||||||||||||||||||||||||||
| Net Cash Flow Growth (1y)NCF Growth (1y) | 88.73% | -56.04% | -455.25% | |||||||||||||||||||||||||||||||||||
| Income After Tax Growth (1y) | -1.55% | -37.71% | ||||||||||||||||||||||||||||||||||||
| Free Cash Flow Growth (5y)FCF Growth (5y) | 35.22% | 28.23% | ||||||||||||||||||||||||||||||||||||
| Free Cash Flow Growth (3y)FCF Growth (3y) | 0.83% | |||||||||||||||||||||||||||||||||||||
| Free Cash Flow Growth (1y)FCF Growth (1y) | 91.54% | -100.19% | -475.87% | |||||||||||||||||||||||||||||||||||
| EPS (Diluted) Growth (1y) | -1.55% | -37.71% | ||||||||||||||||||||||||||||||||||||
| EPS (Basic) Growth (1y) | -1.55% | -37.71% | ||||||||||||||||||||||||||||||||||||
| EBT Growth (1y) | -1.55% | -37.71% | ||||||||||||||||||||||||||||||||||||
| EBIT Growth (1y) | -1.55% | -37.71% | ||||||||||||||||||||||||||||||||||||
| Cash from Operations Growth (5y)Cash from Ops. Growth (5y) | 34.74% | 28.19% | ||||||||||||||||||||||||||||||||||||
| Cash from Operations Growth (3y)Cash from Ops. Growth (3y) | 0.82% | |||||||||||||||||||||||||||||||||||||
| Cash from Operations Growth (1y)Cash from Ops. Growth (1y) | 91.23% | -93.60% | -474.49% | |||||||||||||||||||||||||||||||||||
| Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y) | 84.56% | 8.53% | ||||||||||||||||||||||||||||||||||||
| Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) | -5.99% | |||||||||||||||||||||||||||||||||||||
| Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y) | 18.00% | 24.36% | 21.52% | -2.01% | -78.17% | -20.71% | -21.14% | -25.09% | 1.16% | -0.22% | 5.52% | 7.32% | 2.01% | -1.38% | 327.27% | -3.58% | -19.84% | 27.94% | 4.11% | 3.99% | ||||||||||||||||||
| Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y) | 19.87% | -19.44% | -17.82% | -25.24% | -93.85% | -22.13% | -25.36% | -27.84% | 20.19% | 23.58% | 1,556.12% | 33.41% | 26.21% | 18.22% | -32.17% | -26.45% | -52.80% | -3.29% | 24.34% | 34.99% | ||||||||||||||||||
| Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) | -19.37% | -21.26% | -24.31% | -33.45% | -99.96% | -9.89% | 144,279.64% | -37.33% | 216.00% | 234.25% | -0.44% | 13.37% | -36.09% | -56.40% | -50.94% | -19.50% | -66.45% | 157.72% | 1,067.88% | 18.56% | ||||||||||||||||||
| Capital Expenditures Growth (1y)Capex Growth (1y) | 84.56% | 8.53% | ||||||||||||||||||||||||||||||||||||
| Assets (QoQ) | -14.48% | |||||||||||||||||||||||||||||||||||||
| Assets Growth (5y) | 23.38% | -69.50% | 5.13% | -2.79% | -78.54% | -18.68% | -20.81% | 191.95% | 0.46% | 298.24% | 8.16% | 329.69% | 5.73% | 5.62% | 332.89% | -1.72% | -8.34% | 34.59% | 5.80% | 4.65% | ||||||||||||||||||
| Assets Growth (3y) | 0.19% | -92.09% | -19.34% | 653.95% | -92.92% | 721.07% | -22.75% | 605.02% | 18.94% | 22.41% | 1,384.10% | 26.85% | 30.59% | 38.49% | -19.24% | -20.28% | -41.38% | 1.85% | 19.06% | 20.54% | ||||||||||||||||||
| Assets Growth (1y) | -21.74% | -22.88% | -22.31% | 70,706.79% | -99.94% | 1.36% | 101,674.48% | -51.17% | 183.60% | 270.64% | 13.25% | 12.78% | -30.66% | -36.46% | -32.93% | -29.30% | -56.70% | 135.20% | 481.15% | 5.33% |
Pull Alterity Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=ATHE&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "ATHE", "statement": "Growth", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=ATHE&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();